Skip to main navigation
  • Skip to main content
  • Skip to footer
Scholar Rock

Scholar Rock - Utility Menu

  • Careers
  • Contact Us

Main navigation

  • Our Company
    • Management Team
    • Board of Directors
    • Partnering
    • Learn About Our Company
  • Our Science
    • Structural Insights & the Growth Factor Precursor
    • Platform
    • Publications & Posters
    • Learn About Our Science
  • Our Pipeline
    • Spinal Muscular Atrophy
    • Oncology
    • Fibrosis
    • Iron-Restricted Anemia
    • Clinical Trials
    • Learn About Our Pipeline
  • Patients & Families
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Committee Composition
      • Management Team
      • Board of Directors
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR

Breadcrumb

Home / Investors & Media / Gregory J. Carven, PhD

Gregory J. Carven, PhD

Explore Investors & Media

  • Investor Overview
  • Press Releases
    • Archived Press Releases
  • Events & Presentations
  • Corporate Governance
    • Committee Composition
    • Management Team
    • Board of Directors
  • Financials & Filings
    • SEC Filings
  • Stock Information
    • Historical Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Investor FAQs
  • Contact IR
Dr. Gregory J. Carven has served as Chief Scientific Officer (CSO) since February 2021 and joined Scholar Rock in 2014 as VP of Antibody Discovery and Protein Sciences and was promoted to Head of Research in June 2020. He is a recognized leader, with more than 15 years of experience in the discovery and development of antibody therapeutics. Gregory was recognized for the invention of Keytruda® (pembrolizumab) with his receipt of an award for “Inventor of the Year” in 2016 by the Intellectual Property Owners Education Foundation. Prior to joining Scholar Rock, Gregory led hybridoma based antibody discovery efforts at Pfizer and held positions of increasing responsibility at Merck Research Laboratories (formerly Schering Plough Research Institute and Organon Biosciences), and was a scientist at Phylogix, Inc. Gregory received his PhD in Biological Chemistry from the Massachusetts Institute of Technology, and continued his research at the University of Massachusetts Medical School. 
thumbnail
Gregory J. Carven, PhD
Chief Scientific Officer
    • RSS Feeds
    • Search

    Footer

    SCHOLAR ROCK
    620 Memorial Dr 2nd Floor
    Cambridge, MA 02139

    MOVING EARLY 2021 TO
    301 Binney Street, 3rd Floor
    Cambridge, MA 02142

    Phone: 857.259.3860
    info@scholarrock.com

    Contact Us

    LinkedIn Twitter

    Scholar Rock - Main navigation

    • Our Company
      • Management Team
      • Board of Directors
      • Partnering
      • Learn About Our Company
    • Our Science
      • Structural Insights & the Growth Factor Precursor
      • Platform
      • Publications & Posters
      • Learn About Our Science
    • Our Pipeline
      • Spinal Muscular Atrophy
      • Oncology
      • Fibrosis
      • Iron-Restricted Anemia
      • Clinical Trials
      • Learn About Our Pipeline
    • Patients & Families
    • Investors & Media
      • Press Releases
        • Archived Press Releases
      • Events & Presentations
      • Corporate Governance
        • Committee Composition
        • Management Team
        • Board of Directors
      • Financials & Filings
        • SEC Filings
      • Stock Information
        • Historical Stock Lookup
        • Investment Calculator
        • Analyst Coverage
      • Investor FAQs
      • Contact IR
    • Community Guidelines
    • Expanded Access Policy
    • Terms of Use
    • Privacy Policy

    Scholar Rock, Inc. © 2021 All Rights Reserved

      Scholar Rock - Main navigation

    • Our Company
      • Management Team
      • Board of Directors
      • Partnering
      • Learn About Our Company
    • Our Science
      • Structural Insights & the Growth Factor Precursor
      • Platform
      • Publications & Posters
      • Learn About Our Science
    • Our Pipeline
      • Spinal Muscular Atrophy
      • Oncology
      • Fibrosis
      • Iron-Restricted Anemia
      • Clinical Trials
      • Learn About Our Pipeline
    • Patients & Families
    • Investors & Media
      • Press Releases
        • Archived Press Releases
      • Events & Presentations
      • Corporate Governance
        • Committee Composition
        • Management Team
        • Board of Directors
      • Financials & Filings
        • SEC Filings
      • Stock Information
        • Historical Stock Lookup
        • Investment Calculator
        • Analyst Coverage
      • Investor FAQs
      • Contact IR
    • Scholar Rock - Utility Menu

    • Careers
    • Contact Us